RegenLab USA Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	0.38
Debt / Equity	n/a
Debt / EBITDA	11.27
Debt / FCF	14.30
Interest Coverage	0.66

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	$271,320
Profits Per Employee	-$5,690
Employee Count	200
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-127,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RegenLab USA had revenue of $54.26 million and -$1.14 million in losses.

Revenue	54.26M
Gross Profit	37.49M
Operating Income	3.54M
Pretax Income	-1.27M
Net Income	-1.14M
EBITDA	3.55M
EBIT	2.47M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has $4.83 million in cash and $40.04 million in debt, with a net cash position of -$35.22 million.

Cash & Cash Equivalents	4.83M
Total Debt	40.04M
Net Cash	-35.22M
Net Cash Per Share	n/a
Equity (Book Value)	-9.75M
Book Value Per Share	n/a
Working Capital	-12.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $4.09 million and capital expenditures -$1.29 million, giving a free cash flow of $2.80 million.

Operating Cash Flow	4.09M
Capital Expenditures	-1.29M
Depreciation & Amortization	1.09M
Net Borrowing	n/a
Free Cash Flow	2.80M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 69.08%, with operating and profit margins of 6.53% and -2.10%.

Gross Margin	69.08%
Operating Margin	6.53%
Pretax Margin	-2.33%
Profit Margin	-2.10%
EBITDA Margin	6.55%
EBIT Margin	4.55%
FCF Margin	5.16%

Dividends & Yields

RegenLab USA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
FCF Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a